The agency said it will not take action against pharmacies making copies of Eli Lilly’s blockbuster drug while it reevaluates ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

Eli Lilly shares continue to soar thanks to its new weight loss drugs. With sales of Mounjaro and ZepBound continuing to ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...

At a protest in San Francisco, blind Uber and Lyft users claim that the ride-hailing companies aren’t doing enough to prevent ...

There are several types of GLP-1 medications available, each with varying dosing schedules and forms of administration. Some ...

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...

In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Over the last couple of years, pharmaceutical giant Eli Lilly (NYSE: LLY) has made a splash in the red-hot weight loss space.

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been given an average rating of “Moderate Buy” by the nineteen research firms that are covering the stock, Ratings reports. Three ...